Skip to main content
. 2018 Jul 7;24(10):2093–2103. doi: 10.1093/ibd/izy222

FIGURE 3.

FIGURE 3.

Persistence of chronic opioid therapy. Kaplan-Meier analyses were conducted to determine persistence of chronic opioid therapy for adolescents and young adults with IBD who filled ≥2 opioid prescriptions in an index year and remained in the database for ≥3 subsequent years. Analyses showed that 30.5% continued to receive chronic opioid therapy in year 2, 10.7% in year 3, and 5.3% in year 4.